GLP-1 analog outperforms sulfonylurea in type 2 diabetes
Links shared publicly online about this topic.
- 1,967total visits
GLP-1 analog outperforms sulfonylurea in type 2 diabetes
In a head-to-head comparison, liraglutide reduced A1C levels more effectively with virtually no hypoglycemia and with weight loss, compared with weight gain with glimepiride.
View full resource at theheart.org
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Type 2 Diabetes, Low Blood Sugar, Weight Loss, Amaryl, Victoza
Most Recently Shared on June 15, 2009 at 6:05 pm By:
heartwire: GLP-1 inhibitor outperforms sulfonylurea in type 2 diabetes http://bit.ly/vgZEm
Advertisement
